Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States

被引：29

作者：

Sembower, Mark A. ^{[1
]}

Ertischek, Michelle D. ^{[2
]}

Buchholtz, Chloe ^{[3
]}

Dasgupta, Nabarun ^{[4
]}

Schnoll, Sidney H. ^{[2
]}

机构：

[1] Pinney Associates, Pittsburgh, PA USA

[2] Pinney Associates, Bethesda, MD USA

[3] Denver Hlth & Hosp Author, Denver, CO USA

[4] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

来源：

JOURNAL OF ADDICTIVE DISEASES | 2013年 / 32卷 / 01期

关键词：

Attention-deficit hyperactivity disorder; amphetamine; methylphenidate; psycho-; stimulants; substance abuse and dependence; OPIOID ANALGESICS; ABUSE; ADHD; MISUSE; TEXAS;

D O I：

10.1080/10550887.2012.759880

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

This article examines rates of nonmedical use and diversion of extended-release amphetamine and extended-release oral methylphenidate in the United States. Prescription dispensing data were sourced from retail pharmacies. Nonmedical use data were collected from the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System Drug Diversion Program and Poison Center Program. Drug diversion trends nearly overlapped for extended-release amphetamine and extended-release oral methylphenidate. Calls to poison centers were generally similar; however, calls regarding extended-release amphetamine trended slightly lower than those for extended-release oral methylphenidate. Data suggest similar diversion and poison center call rates for extended-release amphetamine and extended-release oral methylphenidate.

引用

页码：26 / 38

页数：13

共 22 条

[1] [Anonymous], AAPCC NAT POIS DAT S
[2] The effect of FDA approval of a generic competitor to OxyContin® (oxycodone HCl controlled-release) tablets on the abuse of oxycodone
Bailey, J. Elise
Barton, Phoebe Lindsey
Lezotte, Dennis
Lowenstein, Steven R.
Dart, Richard C.
[J]. DRUG AND ALCOHOL DEPENDENCE, 2006, 84 (02) : 182 - 187
[3] The development of a comprehensive risk-management program for prescription opioid analgesics:: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®)
Cicero, Theodore J.
Dart, Richard C.
Inciardi, James A.
Woody, George E.
Schnoll, Sidney
Munoz, Alvaro
[J]. PAIN MEDICINE, 2007, 8 (02) : 157 - 170
[4] Post-marketing Surveillance of Methadone and Buprenorphine in the United States
Dasgupta, Nabarun
Bailey, Elise J.
Cicero, Theodore
Inciardi, James
Parrino, Mark
Rosenblum, Andrew
Dart, Richard C.
[J]. PAIN MEDICINE, 2010, 11 (07) : 1078 - 1091
[5] Adderall abuse in Texas, 1998-2004
Forrester, Mathias B.
[J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2007, 70 (07): : 658 - 664
[6] Methylphenidate abuse in Texas, 1998-2004
Forrester, Mathias B.
[J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2006, 69 (12): : 1145 - 1153
[7] Active surveillance of abused and misused prescription opioids using poison center data: A pilot study and descriptive comparison
Hughes, Alice A.
Bogdan, Gregory M.
Dart, Richard C.
[J]. CLINICAL TOXICOLOGY, 2007, 45 (02): : 144 - 151
[8] IMS Health, 2011, PLYM M PA IMS HLTH I
[9] The diversion of Ultram®, Ultracet®, and generic tramadol HCl
Inciardi, James A.
Cicero, Theodore J.
Munoz, Alvaro
Adams, Edgar H.
Geller, Anne
Senay, Edward C.
Woody, George E.
[J]. JOURNAL OF ADDICTIVE DISEASES, 2006, 25 (02) : 53 - 58
[10] Inciardi James A, 2007, Law Enforc Exec Forum, V7, P127

← 1 2 3 →